The Optum-backed round was led by Leerink Transformation Partners and will fund the home medical test provider's international expansion plans.

Hanwha Asset Management contributed to a round that boosted the online life insurance provider's overall funding to about $140m.

GumGum's dental tools spinoff has raised $11m from Craft Ventures and undisclosed strategic dental industry partners.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.

Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.

BGI's gene sequencer spinoff, MGI Tech, has secured $200m in funding from Goldstone Investment, Green Pine Capital and Orient Securities despite a reported $1bn target.

Pfizer, Takeda and Alphabet-backed degenerative disease drug developer Cortexyme priced its initial public offering in the middle of its range to raise $75m.

Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.

TigerMed-backed brain monitor developer Neural Analytics boosted its total funding to $66m in a series C round led by existing investor Alpha Edison.